These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38016697)

  • 1. Time after time: failure to identify and support females with ADHD - a Swedish population register study.
    Skoglund C; Sundström Poromaa I; Leksell D; Ekholm Selling K; Cars T; Giacobini M; Young S; Kopp Kallner H
    J Child Psychol Psychiatry; 2024 Jun; 65(6):832-844. PubMed ID: 38016697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.
    Sun S; Kuja-Halkola R; Faraone SV; D'Onofrio BM; Dalsgaard S; Chang Z; Larsson H
    JAMA Psychiatry; 2019 Nov; 76(11):1141-1149. PubMed ID: 31389973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden.
    Skoglund C; Kopp Kallner H; Skalkidou A; Wikström AK; Lundin C; Hesselman S; Wikman A; Sundström Poromaa I
    JAMA Netw Open; 2019 Oct; 2(10):e1912463. PubMed ID: 31577361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
    Liman C; Schein J; Wu A; Huang X; Thadani S; Childress A; Kollins SH; Bhattacharjee S
    BMC Psychiatry; 2024 Sep; 24(1):618. PubMed ID: 39285361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population.
    Martin J; Taylor MJ; Rydell M; Riglin L; Eyre O; Lu Y; Lundström S; Larsson H; Thapar A; Lichtenstein P
    J Child Psychol Psychiatry; 2018 Aug; 59(8):908-916. PubMed ID: 29451303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.
    Kosidou K; Dalman C; Widman L; Arver S; Lee BK; Magnusson C; Gardner RM
    Biol Psychiatry; 2017 Nov; 82(9):651-659. PubMed ID: 27889187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity - a population-based familial coaggregation study in Sweden.
    Chen Q; Kuja-Halkola R; Sjölander A; Serlachius E; Cortese S; Faraone SV; Almqvist C; Larsson H
    J Child Psychol Psychiatry; 2017 Jun; 58(6):711-718. PubMed ID: 28121008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study.
    Lyhmann I; Widding-Havneraas T; Bjelland I; Markussen S; Elwert F; Chaulagain A; Mykletun A; Halmøy A
    BMJ Ment Health; 2024 Sep; 27(1):. PubMed ID: 39304209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare utilization and costs of psychiatric and somatic comorbidities associated with newly diagnosed adult ADHD.
    Garcia-Argibay M; Pandya E; Ahnemark E; Werner-Kiechle T; Andersson LM; Larsson H; Du Rietz E
    Acta Psychiatr Scand; 2021 Jul; 144(1):50-59. PubMed ID: 33749845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden.
    Ljung T; Chen Q; Lichtenstein P; Larsson H
    JAMA Psychiatry; 2014 Aug; 71(8):958-64. PubMed ID: 24964928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention Deficit/Hyperactivity Disorder and risk for non-affective psychotic disorder: The role of ADHD medication and comorbidity, and sibling comparison.
    Björkenstam E; Pierce M; Björkenstam C; Dalman C; Kosidou K
    Schizophr Res; 2020 Apr; 218():124-130. PubMed ID: 32001080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study.
    Du Rietz E; Jangmo A; Kuja-Halkola R; Chang Z; D'Onofrio BM; Ahnemark E; Werner-Kiechle T; Larsson H
    J Child Psychol Psychiatry; 2020 Sep; 61(9):959-968. PubMed ID: 32115717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the childhood symptom profile of community-based individuals diagnosed with attention-deficit/hyperactivity disorder as adults.
    Taylor MJ; Larsson H; Gillberg C; Lichtenstein P; Lundström S
    J Child Psychol Psychiatry; 2019 Mar; 60(3):259-266. PubMed ID: 30338854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment.
    Mowlem FD; Rosenqvist MA; Martin J; Lichtenstein P; Asherson P; Larsson H
    Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):481-489. PubMed ID: 30097723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe.
    Karlsdotter K; Bushe C; Hakkaart L; Sobanski E; Kan CC; Lebrec J; Kraemer S; Dieteren NA; Deberdt W
    Curr Med Res Opin; 2016 Sep; 32(9):1547-56. PubMed ID: 27171913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.